|
1
|
Moyzis RK, Buckingham JM, Cram LS, et al:
A highly conserved repetitive DNA sequence, (TTAGGG)n, present at
the telomeres of human chromosomes. Proc Natl Acad Sci USA.
85:6622–6626. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Counter CM, Avilion AA, LeFeuvre CE,
Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere
shortening associated with chromosome instability is arrested in
immortal cells which express telomerase activity. EMBO J.
11:1921–1929. 1992.PubMed/NCBI
|
|
3
|
Harley CB, Futcher AB and Greider CW:
Telomeres shorten during ageing of human fibroblasts. Nature.
345:458–460. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Greider CW and Blackburn EH:
Identification of a specific telomere terminal transferase activity
in Tetrahymena extracts. Cell. 43:405–413. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Allsopp RC, Vaziri H, Patterson C, et al:
Telomere length predicts replicative capacity of human fibroblasts.
Proc Natl Acad Sci USA. 89:10114–10118. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brouilette SW, Moore JS, McMahon AD, et
al: Telomere length, risk of coronary heart disease, and statin
treatment in the West of Scotland Primary Prevention Study: a
nested case-control study. Lancet. 369:107–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McGrath M, Wong JYY, Michaud D, Hunter DJ
and de Vivo I: Telomere length, cigarette smoking, and bladder
cancer risk in men and women. Cancer Epidemiol Biomarkers Prev.
16:815–819. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Willeit P, Willeit J, Mayr A, et al:
Telomere length and risk of incident cancer and cancer mortality.
JAMA. 304:69–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Artandi SE, Chang S, Lee SL, Alson S,
Gottlieb GJ, Chin L and DePinho RA: Telomere dysfunction promotes
non-reciprocal translocations and epithelial cancers in mice.
Nature. 406:641–645. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Slagboom PE, Droog S and Boomsma DI:
Genetic determination of telomere size in humans: a twin study of
three age groups. Am J Hum Genet. 55:876–882. 1994.PubMed/NCBI
|
|
11
|
Vasa-Nicotera M, Brouilette S, Mangino M,
et al: Mapping of a major locus that determines telomere length in
humans. Am J Hum Genet. 76:147–151. 2005. View Article : Google Scholar :
|
|
12
|
Njajou OT, Cawthon RM, Damcott CM, et al:
Telomere length is paternally inherited and is associated with
parental lifespan. Proc Natl Acad Sci USA. 104:12135–12139. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huda N, Tanaka H, Herbert BS, Reed T and
Gilley D: Shared environmental factors associated with telomere
length maintenance in elderly male twins. Aging Cell. 6:709–713.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Graakjaer J, Bischoff C, Korsholm L, et
al: The pattern of chromosome-specific variations in telomere
length in humans is determined by inherited, telomere-near factors
and is maintained throughout life. Mech Ageing Dev. 124:629–640.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Graakjaer J, Londoño-Vallejo JA,
Christensen K and Kølvraa S: The pattern of chromosome-specific
variations in telomere length in humans shows signs of heritability
and is maintained through life. Ann NY Acad Sci. 1067:311–316.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiang YJ, Calado RT, Hathcock KS,
Lansdorp PM, Young NS and Hodes RJ: Telomere length is inherited
with resetting of the telomere set-point. Proc Natl Acad Sci USA.
107:10148–10153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wu X, Amos CI, Zhu Y, et al: Telomere
dysfunction: a potential cancer predisposition factor. J Natl
Cancer Inst. 95:1211–1218. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kirwan MJ, Vulliamy T, Marrone A, et al:
Defining the pathogenic role of telomerase mutations in
myelodysplastic syndrome and acute myeloid leukemia. Hum Mutat.
30:1567–1573. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Swerdlow SH, Campo E, Harris NL, et al:
WHO Classification of Tumours of Haematopoietic and Lymphoid
Tissues. IARC; Lyon: 2008
|
|
20
|
Goldin LR, Björkholm M, Kristinsson SY,
Turesson I and Landgren O: Elevated risk of chronic lymphocytic
leukemia and other indolent non-Hodgkin’s lymphomas among relatives
of patients with chronic lymphocytic leukemia. Haematologica.
94:647–653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu K, Lund M, Bang K and Thestrup-Pedersen
K: Telomerase activity and telomere length in lymphocytes from
patients with cutaneous T-cell lymphoma. Cancer. 86:1056–1063.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Terasaki Y, Okumura H, Ohtake S and Nakao
S: Accelerated telomere length shortening in granulocytes: a
diagnostic marker for myeloproliferative diseases. Exp Hematol.
30:1399–1404. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu KD, Orme LM, Shaughnessy J, Jacobson J,
Barlogie B and Moore MAS: Telomerase and telomere length in
multiple myeloma: correlations with disease heterogeneity,
cytogenetic status, and overall survival. Blood. 101:4982–4989.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hartmann U, Brümmendorf TH, Balabanov S,
Thiede C, Illme T and Schaich M: Telomere length and hTERT
expression in patients with acute myeloid leukemia correlates with
chromosomal abnormalities. Haematologica. 90:307–316.
2005.PubMed/NCBI
|
|
25
|
Ghaffari SH, Shayan-Asl N, Jamialahmadi
AH, Alimoghaddam K and Ghavamzadeh A: Telomerase activity and
telomere length in patients with acute promyelocytic leukemia:
indicative of proliferative activity, disease progression, and
overall survival. Ann Oncol. 19:1927–1934. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Capraro V, Zane L, Poncet D, et al:
Telomere deregulations possess cytogenetic, phenotype, and
prognostic specificities in acute leukemias. Exp Hematol.
39:195–202.e2. 2011. View Article : Google Scholar
|
|
27
|
Lan Q, Cawthon R, Shen M, et al: A
prospective study of telomere length measured by monochrome
multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin
Cancer Res. 15:7429–7433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mansouri L, Grabowski P, Degerman S, et
al: Short telomere length is associated with NOTCH1/SF3B1/TP53
aberrations and poor outcome in newly diagnosed chronic lymphocytic
leukemia patients. Am J Hematol. 88:647–651. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tegg EM, Thomson RJ, Stankovich J, et al:
Evidence for a common genetic aetiology in high-risk families with
multiple haematological malignancy subtypes. Br J Haematol.
150:456–462. 2010.PubMed/NCBI
|
|
30
|
Tegg EM, Thomson RJ, Stankovich JM, et al:
Anticipation in familial hematologic malignancies. Blood.
117:1308–1310. 2011. View Article : Google Scholar
|
|
31
|
Lowenthal RM, Tegg EM and Dickinson JL:
The Familial Tasmanian Haematological Malignancies Study (FaTHMS):
its origins, its history and the phenomenon of anticipation.
Transfus Apher Sci. 49:113–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
FitzGerald LM, Patterson B, Thomson R, et
al: Identification of a prostate cancer susceptibility gene on
chromosome 5p13q12 associated with risk of both familial and
sporadic disease. Eur J Hum Genet. 17:368–377. 2009. View Article : Google Scholar
|
|
33
|
Callisaya ML, Blizzard L, Schmidt MD,
Martin KL, McGinley JL, Sanders LM and Srikanth VK: Gait, gait
variability and the risk of multiple incident falls in older
people: a population-based study. Age Ageing. 40:481–487. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Giles GG, Lickiss JN, Baikie MJ, Lowenthal
RM and Panton J: Myeloproliferative and lymphoproliferative
disorders in Tasmania, 1972–80: occupational and familial aspects.
J Natl Cancer Inst. 72:1233–1240. 1984.PubMed/NCBI
|
|
35
|
Lickiss JN, Giles GG, Baikie MJ, Lowenthal
RM, Challis D and Panton J: Myeloproliferative and
lymphoproliferative disorders in Tasmania, 1972–80: patterns in
space and time. J Natl Cancer Inst. 72:1223–1231. 1984.PubMed/NCBI
|
|
36
|
Cawthon RM: Telomere length measurement by
a novel monochrome multiplex quantitative PCR method. Nucleic Acids
Res. 37:e212009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ruijter JM, Ramakers C, Hoogaars WMH,
Karlen Y, Bakker O, van den Hoff MJB and Moorman AFM: Amplification
efficiency: linking baseline and bias in the analysis of
quantitative PCR data. Nucleic Acids Res. 37:e452009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Almasy L and Blangero J: Multipoint
quantitative-trait linkage analysis in general pedigrees. Am J Hum
Genet. 62:1198–1211. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Almasy L and Blangero J: Variance
component methods for analysis of complex phenotypes. Cold Spring
Harb Protoc. 2010.pdb.top77-pdb.top77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Njajou OT, Blackburn EH, Pawlikowska L, et
al: A common variant in the telomerase RNA component is associated
with short telomere length. PLoS One. 5:e130482010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kampstra P: Beanplot: A boxplot
alternative for visual comparison of distributions. J Statistical
Software. 28:1–9. 2008.http://www.jstatsoft.org/v28/c01/.
|
|
42
|
Aubert G, Baerlocher GM, Vulto I, Poon SS
and Lansdorp PM: Collapse of telomere homeostasis in hematopoietic
cells caused by heterozygous mutations in telomerase genes. PLoS
Genet. 8:e10026962012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Schröder CP, Wisman GB, de Jong S, et al:
Telomere length in breast cancer patients before and after
chemotherapy with or without stem cell transplantation. Br J
Cancer. 84:1348–1353. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mirabello L, Garcia-Closas M, Cawthon R,
et al: Leukocyte telomere length in a population-based case-control
study of ovarian cancer: a pilot study. Cancer Causes Control.
21:77–82. 2010. View Article : Google Scholar
|
|
45
|
Engelhardt M, Ozkaynak MF, Drullinsky P,
Sandoval C, Tugal O, Jayabose S and Moore MA: Telomerase activity
and telomere length in pediatric patients with malignancies
undergoing chemotherapy. Leukemia. 12:13–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Franco S, Ozkaynak MF, Sandoval C, Tugal
O, Jayabose S, Engelhardt M and Moore MAS: Telomere dynamics in
childhood leukemia and solid tumors: a follow-up study. Leukemia.
17:401–410. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Diker-Cohen T, Uziel O, Szyper-Kravitz M,
Shapira H, Natur A and Lahav M: The effect of chemotherapy on
telomere dynamics: clinical results and possible mechanisms. Leuk
Lymphoma. 54:2023–2029. 2013. View Article : Google Scholar
|
